Ipecac syrup abuse, morbidity, and mortality: Isn't it time to repeal its over-the-counter status?

Journal of Adolescent Health

Volumn 37, Issue 3, 2005, Pages 256-260

  Silber, Tomas J ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cardiomyopathy; Eating disorders; Ipecac abuse; Ipecac toxicity; Myositis

Indexed keywords

CREATINE PHOSPHATE; EMETINE; FRUCTOSE BISPHOSPHATE ALDOLASE; IPECAC; NON PRESCRIPTION DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALKALOSIS; BLOOD LEVEL; CHILD PSYCHIATRY; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; DEATH; DIARRHEA; DRUG ABUSE; EATING DISORDER; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ESOPHAGUS DISEASE; FEMALE; HEART ARRHYTHMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOKALEMIA; MALLORY WEISS SYNDROME; MEDLINE; METABOLIC DISORDER; MORBIDITY; MORTALITY; MYOCARDITIS; MYOSITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; STOMACH DISEASE; TISSUE LEVEL; TOXICITY; URINE LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EATING DISORDERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMETICS; EMETINE; FEMALE; HUMANS; IPECAC; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 23744471706     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2004.08.022     Document Type: Review

References (76)

1. Federal Register 50 1985 12944
2. Federal Register 40 1975 12939
3. Ipecac syrup. Vol. OTC 21 CFR 201.308 (1965).
4. R.A. Curtis, J. Barone, N. Giacona Efficacy of ipecac and activated charcoal/cathartic Arch Intern Med 144 1984 48 52
5. P.S. Auerbach, J. Osterich, O. Braun Efficacy of gastric emptying. Gastric lavage versus emesis induced by ipecac Ann Emerg Med 15 1986 692 698
6. M. Tenenbein, S. Cohen, D.S. Sitar Efficacy of ipecac induced emesis, orogastric lavage and activated charcoal for acute drug overdose Ann Emerg Med 16 1987 838 841
7. D. Tandberg, B.G. Dinen, J.W. McLeod Ipecac-induced emesis versus gastric lavage A controlled study in normal volunteers Am J Emerg Med 4 1986 205 209
8. J.A. Cordonnier, M.A. Van den Heede, A.M. Heyndrickx Activated charcoal and ipecac syrup in prevention in tilidine absorption in man Vet Hum Toxicol 29 1987 105 106
9. V. Danel, J.A. Henry, E. Glucksman Activated charcoal, emesis and gastric lavage in aspirin overdose Br Med J 296 1988 1507 1508
10. T.E. Albertson, R.W. Derlet, E. Foulke Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute and toxic ingestions Ann Emerg Med 18 1989 56 59
11. K.S. Merigian, M. Woodard, J.R. Hedges Prospective evaluation of gastric emptying in the self poisoned patient Am J Emerg Med 8 1990 479 483
12. P.J. Neuvonen, K.T. Olkkola Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metaclopramide as an antiemetic agent J Toxicol Clin Toxicol 22 1984 103 114
13. T.J. Underhill, M.K. Greene, A.F. Dove A comparison of the efficacy of gastric lavage, ipecac and activated charcoal in the emergency management of paracetamol overdose Arch Emerg Med 7 1990 148 154
14. A.E. Kornberg, J. Delgin Pediatric ingestions Charcoal alone versus ipecac and charcoal Ann Emerg Med 20 1991 648 651
15. S.M. Pond, Lewis, D.J. Driner Gastric emptying in acute overdoes A prospective randomized trial Med J Aust 163 1995 345 349
16. E.P. Krenzelock, M. McGuigan, P. Lheur Position statement: Ipecac syrup. American Academy of Clinical Toxicology, European Association of Poison Centres and Clinical Toxicologists J Toxicol Clin Toxicol 35 1997 699 709
17. E.P. Krenzelock New developments in the therapy of intoxications Toxicology Lett 127 2002 299 305
18. American Academy of Pediatrics Poison treatment in the home Pediatrics 112 2003 1182 1185
19. Federal Register, 68.24004.
20. Silber TJ. Ipecac Syrup Abuse. Presentation to the Center for Drug Evaluation and Research Office of Executive Programs. US Food and Drug Administration. Bethesda, Maryland. June 12, 2003.
21. Meckcatie E. FDA Panel: Ipecac OTC Status Should be Revoked. Pediatric News 2003, July, p 30.
22. H.J. McClung, R. Murray, N.J. Braden Intentional ipecac poisoning in children Am J Dis Child 142 1988 637 639
23. J.L. Sutphen, F.T. Saulsburg Intentional ipecac poisoning Munchausen syndrome by proxy Pediatrics 82 1988 453 456
24. L. Day, C. Kelly, G. Reed Fatal cardiomyopathy Suspected child abuse by chronic ipecac administration Vet Hum Toxicol 31 1989 255 257
25. R.B. Coletti, R.C. Wasserman Recurrent infantile vomiting due to intentional ipecac poisoning J Ped Gastro Nutr 8 1989 394 396
26. J.E. Johnson, B.L. Carpenter, J. Benton Hemorrhagic colitis and pseudomelanosis coli in ipecac ingestion by proxy J Ped Gastro Nutr 12 1991 501 506
27. J. Goebel, D.A. Greinse, M. Artinan Cardiomyopathy from ipecac administration in Munchausen syndrome by proxy Pediatrics 92 1993 601 603
28. C. Caraccio, K. Blotny, R. Ringel Sudden onset of profound weakness in a toddler J Pediatr 122 1993 663 667
29. D.J. Schneider, A. Perez, T.E. Knilamus Clinical and pathological aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy Pediatrics 97 1996 902 906
30. J.M. Andersen, D.J. Keljo, J.C. Argyle Secretory diarrhea caused by ipecac poisoning J Ped Gastro Nutr 24 1997 612 615
31. C.P. Cooper, K.R. Karmath A toddler with persistent vomiting and diarrhea Eur J Peds 157 1998 775 776
32. A.A. Bader, B. Kerzner Ipecac toxicity in Muchausen syndrome by proxy Therap Drug Monitor 21 1999 259 260
33. H.G. Pope Jr., J.L. Hudson, R.A. Nixon, P.L. Herridge The epidemiology of ipecac abuse N Engl J Med 314 1986 2456 2459
34. M. Story, K. Rosenwinkel, J.H. Himes Demographic and risk factors associated with chronic dieting in adolescents Am J Dis Child 145 1991 994 998
35. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed., Text Revision 2000 APA Washington DC
36. G. Szmukler, C. McCance, L. McCrone, D. Hunter Anorexia Nervosa A psychiatric case register study from Aberdeen Psychol Med 16 1986 49 58
37. A.R. Lucas, C.M. Beard, W.M. O'Fallon, L.T. Kurland Anorexia nervosa in Rochester Minnesota A 45 year study Mayo Clinic 63 1988 433 442
38. D. Jones, M. Fox, H. Baligan, H. Hutton Epidemiology of anorexia nervosa in Monroe County, New York 1960-1976 Psychosom Med 42: 1980 551 558
39. J. Eagles, M. Johnston, D. Hunter Increasing incidence of anorexia nervosa in the female population of northeast Scotland Am J Psychiatry 152 1995 1266 1271
40. J. Willi, G. Giacometti, B. Limacher Update on the epidemiology of anorexia nervosa in a defined region of Switzerland Am J Psychiatry 140 1983 564 567
41. E.D. Eckert, K.A. Halini, P. Marchi Ten year follow-up of anorexia nervosa clinical course and outcome Psychol Med 25 1995 143 156
42. I.C. Gilberg, M. Rastam, C. Gilberg Anorexia nervosa outcome six-year controlled longitudinal study of 51 cases including a population cohort J Am Acad Child Adolesc Psych 33 1994 729 739
43. C. Smith, S. Feldman, A. Nasserbakt, H. Steiner Psychological characteristics and DSM-III-R diagnoses at 6-year-old follow-up of adolescent anorexia nervosa J Am Acad Child Adolesc Psych 32 1993 1237 1245
44. T. Van der Ham, D. Van Strien, H. Van England A four-year prospective study of 49 eating disordered adolescents Differences in course of illness Acta Psychiatr Scand 90 1994 229 235
45. C. Bulik, F. Sullivan, J. Fear, A. Pickering Predictors of the development of bulimia nervosa in women with anorexia nervosa J Nerv Ment Dis 185 1997 704 707
46. A. Drenowski, S.A. Hopkins, R.C. Kessler The prevalence of bulimia nervosa in the US college student population Am J Pub Health 78 1988 1322 1325
47. P. Garfinkel, E. Lin, P. Goering Bulimia nervosa in a Canadian community sample prevalence and comparison of subgroups Am J Psychiatry 152 1995 1052 1058
48. C.S.W. Rand, J.E. Mitchell, E.D. Eckert Epidemiology of bulimia and symptoms in a general population Sex, age, race and socioeconomic status Int J Eat Disord 11 1992 37 44
49. D. Greenfeld, D. Mickley, D.M. Quinlon, P. Roloff Ipecac abuse in a sample of eating disordered outpatients Int J Eat Disord 13 1993 411 414
50. M. Fisher, M. Schneider, J. Burns Differences between adolescents and young adults at presentation to an eating disorders program J Adolesc Health 28 2001 222 227
51. H.H. Anderson, A.C. Reed Untoward effects of anti-amebic drugs Am J Trop Med Hyg 14 1934 269 281
52. L.R. Goldfrank N.E. Flomenbaum N.A. Lewin M.A. Howland R.S. Hoffman L.S. Nelson Goldfrank's Toxicologic Emergencies 7th ed. 2002 McGraw Hill New York
53. G.A. Timberlake Ipecac as a cause of Mallory-Weiss syndrome South Med J 77 1984 804 805
54. D. Tandberg, E.J. Liechty, D. Fishbein Mallory-Weiss syndrome an unusual complication of syrup of ipecac induced emesis Ann Emer Med 10 1981 521 523
55. R.A. Romig The potential toxicity of ipecac Am J Psychiatry 141 1984 1639
56. H.S. Bennett, A.J. Spiro, M.A. Pollack Ipecac-induced myopathy simulating dermatomyositis Neurology 32 1982 91
57. M.C. Brotman, N. Forthbath, P.E. Garfinkel, J.G. Humphrey Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa Can Med Assoc J 125 1981 453 454
58. N.L. Rosenberg, S.P. Ringel Myopathy from surreptitious ipecac ingestion West J Med 145 1986 386 388
59. J.E. Mitchell, H.C. Seim, E. Colon, C. Pomeroy Medical complications and medical management of bulimia Ann Intern Med 107 1987 747 750
60. A.G. Friedman, R.J. Seime, T. Roberts, W.J. Frernouw Ipecac abuse a serious complication in bulimia Gen Hosp Psychiatry 9 1987 2258 2260
61. O.J. Wolowodink, D.B. McMicken, P. O'Brien Pneumomediastinum and retroneumoperitoneum An unusual complication of syrup of ipecac induced-emesis Ann Emerg Med 13 1984 1148 1151
62. L. Halbig, L. Guttman, H.H. Goebel Ultrastructural pathology in emetine induced myopathy Acta Neuropathologica 75 1988 577 582
63. A.G. Adler, P. Walinsky, R.A. Krail, S.Y. Cho Death resulting from ipecac syrup poisoning JAMA 243 1980 1927 1928
64. J.A. Danson, J. Jager A case of abuse of syrup of ipecac resulting in death J Am Cll Health 34 1986 2802 2805
65. R.A. Romig Anorexia nervosa, ipecac, and sudden death Ann Intern Med 103 1985 641 644
66. E.J. Friedman Death from ipecac intoxication in a patient with anorexia nervosa Am J Psychiatry 141 1984 7023 7025
67. R.J. Schiff, C.L. Wurgel, S.C. Brunson Death due to chronic syrup of ipecac use in a patient with bulimia Pediatrics 78 1986 4126 4128
68. Lee L. ODS Postmarketing Safety Review (PID No. D030159) Ipecac Executive Summary Center for Drug Evaluation and Research, FDA. May 6, 2003.
69. E.P. Palmer, A.T. Guay Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders N Engl J Med 313 1985 1457 1459
70. P.C. Ho, R. Dweik, M.C. Cohen Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion Clin Cardio 21 1998 780 783
71. G. Ente, P.H. Penzer New abuse of ipecac Pediatrics 77 1986 1345 1347
72. F. Lachman, R. Romeo, R.B. McComb Emetine identified in urine by HPLC, with fluorescence and ultraviolet/diode array detection in a patient with cardiomyopathy Clin Chem 35 1989 499 502
73. M.A. Eldawy, M.M. Mabrouk, F.A. El-Barbary Determination of chlorpheniramine maleate and tincture ipecac in dosage form by liquid chromatography with ultraviolet detection J Assoc Analyt Chemist Int 84 2003 675 680
74. E.J. Sharman, J.M. Hutzler, J.G. Rosencrance, T.S. Tracy Single dose pharmacokinetics of syrup of ipecac Drug Monit 22 2000 566 573
75. M. Yamashita, M. Yamashita, J. Azuma Urinary excretion of ipecac alkaloids in human volunteers Vet Hum Toxicol 44 2002 257 259
76. M. Shannon The demise of ipecac Pediatrics 112 2003 1180 1181